Profarm sees EU drug-supply antitrust complaint against Amgen rejected
MLex Summary: The European Commission has rejected a complaint from Greek pharmaceutical wholesaler Profarm against medication producer Amgen, according to a decision published on Friday. The complainant was arguing that Amgen...To view the full article, register now.
Already a subscriber? Click here to view full article